Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients

NCT07737977 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT07737977
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07737977 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Developing a Comprehensive Biomarker Panel for Monitoring Progression and Early Detection in ALS Patients
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2026
Completion date
August 31, 2029
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

als (amyotrophic lateral sclerosis)